A carregar...
On the Regulatory Approval Pathway of Biosimilar Products
Biosimilars (or follow-on biologics) are a new class of medicine which enters the market subsequent to a previously approved version. They have demonstrated similarity to innovator biologic products in terms of quality, safety, and efficacy. The EMA has taken the lead in the regulatory approval fram...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2012-03-01
|
| Colecção: | Pharmaceuticals |
| Assuntos: | |
| Acesso em linha: | http://www.mdpi.com/1424-8247/5/4/353/ |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|